Cargando…

Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections

Considering its very short elimination half-life, the approved oxacillin dosage might not be sufficient to maintain the pharmacokinetic/pharmacodynamics (PK/PD) target of time-dependent antibiotics. This study aimed to describe the population pharmacokinetics of oxacillin and to explore the probabil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murínová, Irena, Švidrnoch, Martin, Gucký, Tomáš, Hlaváč, Jan, Michálek, Pavel, Slanař, Ondřej, Šíma, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774644/ https://www.ncbi.nlm.nih.gov/pubmed/36551393 http://dx.doi.org/10.3390/antibiotics11121736

Ejemplares similares

In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin
por: Rodriguez, Carlos A, et al.
Publicado: (2010)

What Is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?
por: Šíma, Martin, et al.
Publicado: (2021)

Dose Optimization and Targeting Strategies of Anti-Infective Agents
por: Šíma, Martin, et al.
Publicado: (2023)

1321. Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analyses for Dalbavancin in Pediatric Patients
por: Carrothers, Timothy J, et al.
Publicado: (2020)

Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation
por: Šantavý, Petr, et al.
Publicado: (2022)

Clonal Diversity, Low-Level and Heterogeneous Oxacillin Resistance of Oxacillin Sensitive MRSA
por: Liu, Roushan, et al.
Publicado: (2021)

850. Outcomes of Patients Discharged on Parenteral Ceftriaxone Compared with Oxacillin or Cefazolin in Methicillin-susceptible Staphylococcal aureus (MSSA) Bloodstream Infections
por: Erik Connor, Lee, et al.
Publicado: (2019)

Oxacillin (Methicillin) Resistant Staphylococci in Domestic Animals in the Czech Republic
por: Bzdil, Jaroslav, et al.
Publicado: (2021)

Oxacillin-induced leukocytoclastic vasculitis
por: Mericliler, Meric, et al.
Publicado: (2019)

1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection
por: Bhavnani, Sujata M, et al.
Publicado: (2018)

Pharmacokinetic Variability in Pre-Clinical Studies: Sample Study with Abiraterone in Rats and Implications for Short-Term Comparative Pharmacokinetic Study Designs
por: Královičová, Jana, et al.
Publicado: (2022)

Sub-Inhibitory Concentrations of Oxacillin, but Not Clindamycin, Linezolid, or Tigecycline, Decrease Staphylococcal Phenol-Soluble Modulin Expression in Community-Acquired Methicillin-Resistant Staphylococcus aureus
por: Hodille, Elisabeth, et al.
Publicado: (2022)

Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin
por: Šíma, Martin, et al.
Publicado: (2022)

Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients
por: Dvořáčková, Eliška, et al.
Publicado: (2022)

1390. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Rezafungin (RZF) Dose Selection in Treatment of Candida
por: Lakota, Elizabeth A, et al.
Publicado: (2018)

Vancomycin and Oxacillin Co-Resistance of Commensal Staphylococci
por: Soyege, Ariyo Oludotun, et al.
Publicado: (2014)

No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses
por: Šíma, Martin, et al.
Publicado: (2021)

Synergism and the mechanism of action of the combination of α-mangostin isolated from Garcinia mangostana L. and oxacillin against an oxacillin-resistant Staphylococcus saprophyticus
por: Phitaktim, Sineewan, et al.
Publicado: (2016)

Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model
por: Dvořáčková, Eliška, et al.
Publicado: (2023)

2560. Individual Meropenem Epithelial Lining Fluid and Plasma PK/PD Target Attainment in Patients with Pneumonia
por: Rohani, Roxane, et al.
Publicado: (2023)

Neutropenia during High Dose Intravenous Oxacillin Therapy
por: Ahern, Mary Jean, et al.
Publicado: (1976)

A Novel Spectrophotometric Method for the Determination Oxacillin Sodium
por: Gujral, Rajinder Singh, et al.
Publicado: (2009)

Profound Neutropenia with Concomitant Hepatitis During Oxacillin Therapy
por: Miller, John B, et al.
Publicado: (2019)

2531. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dosing Regimens for Patients with Staphylococcus aureus Bacteremia (SAB)
por: Bhavnani, Sujata M, et al.
Publicado: (2023)

1099. Evaluation of the Safety and Pharmacokinetics (PK) following Administration of Single and Multiple Doses of Anti-Staphylococcal Lysin, LSVT-1701, in Healthy Adult Subjects
por: Wire, Mary Beth, et al.
Publicado: (2021)

Modulation of mecA Gene Expression by Essential Oil from Salvia sclarea and Synergism with Oxacillin in Methicillin Resistant Staphylococcus epidermidis Carrying Different Types of Staphylococcal Chromosomal Cassette mec
por: Chovanová, Romana, et al.
Publicado: (2016)

Provings
por: Berridge, E. W.
Publicado: (1890)

Provings
por: Dietrick, P.
Publicado: (1896)

Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
por: Hofmann, Jiří, et al.
Publicado: (2023)

976. Population Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analysis of Intravenous Fosfomycin for Treatment of Multidrug-Resistant Gram-Negative Bacterial Infections
por: Wangchinda, Walaiporn, et al.
Publicado: (2023)

Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
por: Sharpe, Alexis, et al.
Publicado: (2019)

Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients
por: Bienert, Agnieszka, et al.
Publicado: (2010)

Accurate Laboratory Detection of Oxacillin Resistance in Staphylococcus aureus: Challenges and Pitfalls
por: Mimica, Marcelo J
Publicado: (2014)

Regulation of Expression of Oxacillin-Inducible Methionine Sulfoxide Reductases in Staphylococcus aureus
por: Baum, Kyle R., et al.
Publicado: (2015)

Role of SCCmec type in resistance to the synergistic activity of oxacillin and cefoxitin in MRSA
por: Reichmann, Nathalie T., et al.
Publicado: (2017)

Detection of Oxacillin/Cefoxitin Resistance in Staphylococcus aureus Present in Recurrent Tonsillitis
por: Messias, Aline Cristine Magalhães Costa, et al.
Publicado: (2023)

Proving of Vaccinium
por: Swan, S.
Publicado: (1887)

Proving of Syphilinum
por: Berridge, E. W.
Publicado: (1882)

Provings of Lachesis
por: Fincke, B.
Publicado: (1882)

Vaccininum, Provings of
por: Fincke, B.
Publicado: (1883)

Cannot write session to /tmp/vufind_sessions/sess_r6rrar3ks7c6jllltg5uq581ji